Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportTechnologist Student: Cardiology

The effects of regadenoson in patients diagnosed with end stage renal disease

Laura Lederer, Mike Gatzke and Ann Voslar
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 2115;
Laura Lederer
1Nuclear Medicine, Froedtert, Milwaukee, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Gatzke
1Nuclear Medicine, Froedtert, Milwaukee, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Voslar
1Nuclear Medicine, Froedtert, Milwaukee, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The effects of regadenoson in patients diagnosed with end stage renal disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The effects of regadenoson in patients diagnosed with end stage renal disease
Laura Lederer, Mike Gatzke, Ann Voslar
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 2115;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The effects of regadenoson in patients diagnosed with end stage renal disease
Laura Lederer, Mike Gatzke, Ann Voslar
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 2115;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Technologist Student: Cardiology

  • Effect of SPECT/CT registration on MPI scans
  • Patient motion on the GE Discovery CZT camera: Investigating the necessity of motion correction
Show more Technologist Student: Cardiology

Technologist Student Papers II: PET & Cardiology

  • Effect of SPECT/CT registration on MPI scans
  • Patient motion on the GE Discovery CZT camera: Investigating the necessity of motion correction
  • Evaluation of PET/CT and Thallium-201 imaging for brain tumors vs. necrosis
Show more Technologist Student Papers II: PET & Cardiology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire